Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Letícia P. Leonart"'
Autor:
Ana M. Della Rocca, Fernanda S. Tonin, Mariana M. Fachi, Alexandre F. Cobre, Vinicius L. Ferreira, Letícia P. Leonart, Giovanna Steffenello-Durigon, Joanita A. G. Del Moral, Luana Lenzi, Roberto Pontarolo
Publikováno v:
Diseases, Vol 9, Iss 2, p 43 (2021)
Burkitt lymphoma/leukemia (BL/L) is an aggressive oncohematological disease. This study evaluated the population-based prognosis and survival on BL/L as well as if BL/L behaved as a risk factor for the development of second primary cancers (SPCs) and
Externí odkaz:
https://doaj.org/article/49a7027c11fe435c9421c1a9cc38b403
Autor:
Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista, Michelle Nadalin, Cicera Pimenta Marcelino, Paula Cristina Pungartnik, Angélica Carreira Dos Santos, Letícia Paula Leonart Garmatter, Maria Aparecida do Carmo Rego, Angélica Nogueira-Rodrigues
Publikováno v:
PLoS ONE, Vol 19, Iss 10, p e0312757 (2024)
The aim of the study is to evaluate the treatment patterns, time to start treatment, and healthcare resources utilization (HCRU) of cervical cancer (CC) patients within the Brazilian public health system (SUS). This is an observational retrospective
Externí odkaz:
https://doaj.org/article/f8d341a60c464e6f92c8c151dcbfa919
Autor:
Astrid Wiens, Helena Hiemisch Lobo Borba, Letícia Paula Leonart, Fernanda Stumpf Tonin, Laiza Maria Steimbach, Ariane Gonçalves Silva de Araújo, Thais Piazza, Vinicius Lins Ferreira, Roberto Pontarolo
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
The aim of this study was to evaluate interruption of treatment with biological drugs and tofacitinib due to adverse events in patients with rheumatoid arthritis. A systematic review was performed in the electronic databases MEDLINE, Cochrane, Scopus
Externí odkaz:
https://doaj.org/article/a95405c99a864032922e33a4ee11483f
Autor:
Mariana Millan Fachi, Letícia Bonancio Cerqueira, Letícia Paula Leonart, Thais Martins Guimarães de Francisco, Roberto Pontarolo
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167107 (2016)
An ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the simultaneous quantification of chlorpropamide, glibenclamide, gliclazide, glimepiride, metformin, nateglinide, pioglitazone, rosiglitazone, and vild
Externí odkaz:
https://doaj.org/article/64b0b5dea17e475b8ef51f7fd7eff4f0
Autor:
Aline F. Bonetti, Camilla Regina de Souza Madeira, V.L. Ferreira, Letícia P. Leonart, Alan G. Gonçalves, Fernanda S. Tonin, Rogerio P. Moritz, Roberto Pontarolo, Angela C. L. B. Trindade, Fernando Fernandez-Llimos, Helena Hiemisch Lobo Borba, Mariana Millan Fachi
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Purpose To quantitatively assess the benefit-risk ratio on the efficacy and safety of all phosphodiesterase type 5 inhibitors (PDE5i) in men with erectile dysfunction. Methods A systematic review with network meta-analysis, surface under the cumulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22eb09f12518c7efa321fe16dd5d612
https://doi.org/10.1007/s00345-020-03233-9
https://doi.org/10.1007/s00345-020-03233-9
Publikováno v:
Neuroendocrinology. 111:388-402
Objectives: To conduct a cost-utility analysis comparing drug strategies involving octreotide, lanreotide, pasireotide, and pegvisomant for the treatment of patients with acromegaly who have failed surgery, from a Brazilian public payer perspective.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec36086196910066380027c4ab14793
https://doi.org/10.1159/000507890
https://doi.org/10.1159/000507890
Autor:
Gustavo Bertol, Carolina G. Garcia, Luana Lenzi, Letícia P. Leonart, João Cleverson Gasparetto, Roberto Pontarolo, João Adriano de Barros
Publikováno v:
Revista Brasileira de Farmacognosia. 30:111-117
Guaco is an herb used to treat respiratory disorders. It is included in the list of drugs offered by the Brazilian health system, however its efficacy has never been assessed by clinical trials. A randomized, double-blind, crossover clinical trial wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fef585e9627ffa5ff5318d2feb1ec61
https://doi.org/10.1007/s43450-020-00006-8
https://doi.org/10.1007/s43450-020-00006-8
Autor:
Mariana Millan Fachi, Vinicius Lins Ferreira, Luana Lenzi, Roberto Pontarolo, Fernanda S. Tonin, Ana M. Della Rocca, Joanita Angela Gonzaga Del Moral, Giovanna Steffenello-Durigon, Alexandre de Fátima Cobre, Letícia P. Leonart
Publikováno v:
Diseases, Vol 9, Iss 43, p 43 (2021)
Diseases
Volume 9
Issue 2
Diseases
Volume 9
Issue 2
Burkitt lymphoma/leukemia (BL/L) is an aggressive oncohematological disease. This study evaluated the population-based prognosis and survival on BL/L as well as if BL/L behaved as a risk factor for the development of second primary cancers (SPCs) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180e299537378f2cce9a52d61e908a04
https://www.mdpi.com/2079-9721/9/2/43
https://www.mdpi.com/2079-9721/9/2/43
Publikováno v:
Current Drug Therapy. 14:210-219
Background:Second generation direct acting-antivirals are safe and effective treatments for chronic hepatitis C patients.Objective:We aimed to conduct a systematic review of case reports and case series to evaluate the safety of the drugs, highlighti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f07fe06c042fcb1ad312ce9bc6d1b28
https://doi.org/10.2174/1574885514666190130162547
https://doi.org/10.2174/1574885514666190130162547
Autor:
Roberto Pontarolo, Mariana Millan Fachi, Fernanda S. Tonin, Inajara Rotta, Letícia P. Leonart, Fernando Fernandez-Llimos
Publikováno v:
Br J Clin Pharmacol
© 2019 The British Pharmacological Society Aims: Despite their overall favourable safety profile, tyrosine kinase inhibitors (TKIs) are related to severe adverse events including haematological toxicities such as anaemia, leucopenia, neutropenia and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b92bcd56c64997327aa2dc1736cbcd9
https://doi.org/10.1111/bcp.13933
https://doi.org/10.1111/bcp.13933